From: Serum caspase-3 levels and mortality are associated in patients with severe traumatic brain injury
−2 log likelihood ratio | Hazard Ratio | 95 % Confidence Interval | P-value | |
---|---|---|---|---|
Model 1: | 274.431 | 3.163 | 1.562–6.405 | 0.001 |
Serum caspase-3 > 0.20 ng/mL | ||||
Model 2: | 263.541 | |||
Serum caspase-3 > 0.20 ng/mL | 2.916 | 1.438–5.917 | 0.003 | |
CT findings (high vs low risk of death) | 3.538 | 1.577–7.940 | 0.002 | |
Model 3: | 234.391 | |||
Serum caspase-3 > 0.20 ng/mL | 2.943 | 1.396–6.203 | 0.005 | |
Glasgow Coma Scale | 0.703 | 0.586–0.845 | <0.001 | |
Model 4: | 240.152 | |||
Serum caspase-3 > 0.20 ng/mL | 3.349 | 1.605–6.990 | 0.001 | |
Age (years) | 1.039 | 1.017–1.061 | 0.001 | |
Model 5: | 209.615 | |||
Serum caspase-3 > 0.20 ng/mL | 2.956 | 1.365–6.403 | 0.006 | |
CT findings (high vs low risk of death) | 4.289 | 1.836–10.016 | 0.001 | |
Glasgow Coma Scale | 0.694 | 0.567–0.849 | <0.001 | |
Age (years) | 1.036 | 1.015–1.058 | 0.001 |